These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8495493)
1. Distinctive expression of lprcg in the heterozygous state on different genetic backgrounds. Ogata Y; Kimura M; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A Cell Immunol; 1993 Apr; 148(1):91-102. PubMed ID: 8495493 [TBL] [Abstract][Full Text] [Related]
2. Autoimmunity in mice bearing lprcg: a novel mutant gene. Kimura M; Matsuzawa A Int Rev Immunol; 1994; 11(3):193-210. PubMed ID: 7930845 [TBL] [Abstract][Full Text] [Related]
3. A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse. Matsuzawa A; Moriyama T; Kaneko T; Tanaka M; Kimura M; Ikeda H; Katagiri T J Exp Med; 1990 Feb; 171(2):519-31. PubMed ID: 2406366 [TBL] [Abstract][Full Text] [Related]
4. Nephritogenicity of the lprcg gene on the MRL background. Kimura M; Ogata Y; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A Immunology; 1992 Jul; 76(3):498-504. PubMed ID: 1526655 [TBL] [Abstract][Full Text] [Related]
5. Genotype-restricted lymphoproliferation in autoimmune lpr mice. Matsuzawa A; Kimura M; Muraiso T; Kominami R; Katagiri T Eur J Immunol; 1991 Jun; 21(6):1535-42. PubMed ID: 2044659 [TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. Watson ML; Rao JK; Gilkeson GS; Ruiz P; Eicher EM; Pisetsky DS; Matsuzawa A; Rochelle JM; Seldin MF J Exp Med; 1992 Dec; 176(6):1645-56. PubMed ID: 1460423 [TBL] [Abstract][Full Text] [Related]
7. Alleviation of renal disease and lymphadenopathy in MRL-Fasp(lrcg)/Fas(lprcg) (MR-lpr(cg)) mice neonatally infected with mouse mammary tumor virus encoding superantigen strongly reactive with TCR Vbeta8.2 element. Matsuzawa A; Yasuda T; Zhang Y; Nagase H; Yoshimoto T; Kimura M; Tsubura A Viral Immunol; 2000; 13(3):297-311. PubMed ID: 11016595 [TBL] [Abstract][Full Text] [Related]
8. Characterization of lymphoproliferation induced by interactions between lprcg and gld genes. Kimura M; Ikeda H; Katagiri T; Matsuzawa A Cell Immunol; 1991 May; 134(2):359-69. PubMed ID: 1827047 [TBL] [Abstract][Full Text] [Related]
9. Lymphadenopathy induced by the cooperation between lprcg and gld genes is of lpr but not of gld phenotype. Matsuzawa A; Katagiri T; Ogata Y; Kominami R; Kimura M Eur J Immunol; 1994 Jul; 24(7):1714-6. PubMed ID: 8026532 [TBL] [Abstract][Full Text] [Related]
10. The Yaa mutation induces the development of autoimmunity in mice heterozygous for the gld (generalized lymphadenopathy disease) mutation. Rosenblatt N; Hartmann KU; Loor F Cell Immunol; 1994 Jul; 156(2):519-28. PubMed ID: 8025960 [TBL] [Abstract][Full Text] [Related]
11. A pivotal role of cell-bound but not soluble CD4 molecules in full development of lupus-like manifestations in MRL-Fas(lprcg)/Fas(lprcg) mice. Zhang Y; Yasuda T; Wang CR; Yoshimoto T; Nagase H; Takamoto M; Tsubura A; Kimura M; Matsuzawa A Clin Exp Immunol; 2000 Oct; 122(1):124-32. PubMed ID: 11012628 [TBL] [Abstract][Full Text] [Related]
12. A crucial role of the thymus in induction by the lprcg gene of lymphadenopathy with autoimmunity in the mouse. Matsuzawa A; Moriyama T; Ogata Y; Katagiri T; Kimura M Immunology; 1992 Apr; 75(4):688-92. PubMed ID: 1592441 [TBL] [Abstract][Full Text] [Related]
13. Serological and histological characterization of the new mutant strain of lpr mice, CBA/KlJms-lprcg/lprcg. Kimura M; Mohri H; Shimada K; Wakabayashi T; Kanai Y; Matsuzawa A Clin Exp Immunol; 1990 Jan; 79(1):123-9. PubMed ID: 2302830 [TBL] [Abstract][Full Text] [Related]
14. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice. Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074 [TBL] [Abstract][Full Text] [Related]
15. Serum IgG from CBA/K1Jms-lprcg/lprcg mice induces interleukin 3 in an interleukin-3-dependent cell line--possible correlation with lymphadenopathy. Sato E; Iwamoto M; Sakihama T; Yokoyama Y; Hamada Y; Matsuzawa A; Akamatsu N; Nakajima Y; Tasaka K Cell Immunol; 1991 Dec; 138(2):372-80. PubMed ID: 1934077 [TBL] [Abstract][Full Text] [Related]
16. Significant role of Fas ligand-binding but defective Fas receptor (CD95) in lymph node hyperplasia composed of abnormal double-negative T cells. Matsuzawa A; Shimizu M; Takeda Y; Nagase H; Sayama K; Kimura M Immunology; 2002 Aug; 106(4):470-5. PubMed ID: 12153509 [TBL] [Abstract][Full Text] [Related]
17. Role of bone marrow cells in autoantibody production and lymphoproliferation in the novel mutant strain of mice, CBA/KlJms-lprcg/lprcg. Kimura M; Katagiri T; Kikuchi Y; Shimada K; Nariuchi H; Wakabayashi T; Matsuzawa A Eur J Immunol; 1991 Jan; 21(1):63-9. PubMed ID: 1703965 [TBL] [Abstract][Full Text] [Related]
18. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome. Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009 [TBL] [Abstract][Full Text] [Related]
19. Cell electrophoretic characterization of abnormally expanded lymphocytes in autoimmune lprcg, lpr, gld and Yaa mice, and of thymocyte subsets. Shimizu M; Sekine K; Matsuzawa A; Iwaguchi T Electrophoresis; 1992 Mar; 13(3):136-42. PubMed ID: 1592043 [TBL] [Abstract][Full Text] [Related]
20. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease. Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]